SUGGESTED LOOK & FEEL FORGLOBAL OPPORTUNITIES PROGRAM

HEADER

BANNER

GLOBAL OPPORTUNITIES PROGRAMCHANGING MARKETS, NEW OPPORTUNITIES

PUBLICATION COVER

PUBLISHED SEPTEMBER 2007

BACKGROUND

These guidelines outline:

• How to produce a new publication • Who pays for publications • The time it takes to produce a new publication • Distribution of publications • How to order existing publications

All Invest Australia publications are developed through the Marketing & Communications team (M&C), in consultation with industry teams, to maintain a strong corporate and professional image. The M&C team provides design, printing and distribution services, whether for print or electronic distribution.

When planning a publication, it is important to involve the M&C team as early as possible and adhere to the following guidelines, which cover both the production and distribution of publications.

HOW DO I PRODUCE A NEW PUBLICATION?

1. Obtain your General Manager's approval to produce a new publication.

2. Fill out a publication brief, which determines: • Messages to communicate • The audience you want to reach • Budget and size of publication • Images to be sourced • Quantity required (if printed) • Translations (if required) • Schedules (design, print, distribution) • Distribution strategy

3. Meet with the Marketing team to finish completing the publication brief, and then have it approved by your General Manager.

KEY CONTACTS

Michelle Chant, Manager, Marketing & CommunicationsEmail: michelle.chant@investaustralia.gov.auPhone: 02 6276 1520

Juliana Fiuza, Assistant Manager, Marketing & CommunicationsEmail: juliana.fiuza@investaustralia.gov.auPhone: 02 6276 1514

Guidelines for the Production & Distribution of Publications

DOCUMENTS FORMAT

Visit:

Australian Pavilion No. 4534

BIO International Convention,

17-20 June, San Diego

Australian biotechnology is helping to make the world a healthier place. The Nobel Prize-winning discovery of the causal link between bacteria and stomach ulcers is just one in a series of

Australian biotechnology is helping to make the world a healthier place. The Nobel Prize-winning discovery of the causal link between bacteria and stomach ulcers is just one in a series of

Australian biotechnology is helping to make the world a healthier place. The Nobel Prize-winning discovery of the causal link between bacteria and stomach ulcers is just one in a series of

Australian biotechnology commercial success stories generating health

include a vaccine for cervical cancer, diagnostic and management tools for asthma and chronic obstructive

Australia’s strength’s are clear:

• Strong drug development pipeline with 154 compounds known to be in human clinical trials (Phase I to III), with 58% in Phases II and III.

• Over two-thirds of new clinical trials announced in Australia in 2007 involved international partners.

• Home to more than 470 core biotechnology companies – 49%

1. Bioshares, 2008 2. Bioshares, 2008 3. Ernst & Young Report, 2006 4. Hopper and Thorburn, 2008

Au Str Al IA At A gl ANC e

• US$35 billion market cap of life sciences companies as at 31 December 2007. 1

• Over US$850 million of capital raised in 2007, a 50% increase on 2006. 2

•

biotechnology companies. 3

• In 2007, there were 399 alliances announced, and 70% were with overseas entities. 4

Australian Biotechnology Helping to heal the world

One discovery at a time

AD